DK1071806T3 - Rekombinant adeno-associeret virus-vektor, der koder for alpha-1-antitrypsin i genterapi - Google Patents

Rekombinant adeno-associeret virus-vektor, der koder for alpha-1-antitrypsin i genterapi

Info

Publication number
DK1071806T3
DK1071806T3 DK99918810T DK99918810T DK1071806T3 DK 1071806 T3 DK1071806 T3 DK 1071806T3 DK 99918810 T DK99918810 T DK 99918810T DK 99918810 T DK99918810 T DK 99918810T DK 1071806 T3 DK1071806 T3 DK 1071806T3
Authority
DK
Denmark
Prior art keywords
gene therapy
methods
antitrypsin
associated virus
vector encoding
Prior art date
Application number
DK99918810T
Other languages
English (en)
Inventor
Terence R Flotte
Sihong Song
Michael Morgan
Barry J Byrne
Original Assignee
Univ Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida filed Critical Univ Florida
Application granted granted Critical
Publication of DK1071806T3 publication Critical patent/DK1071806T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK99918810T 1998-04-24 1999-04-23 Rekombinant adeno-associeret virus-vektor, der koder for alpha-1-antitrypsin i genterapi DK1071806T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8302598P 1998-04-24 1998-04-24

Publications (1)

Publication Number Publication Date
DK1071806T3 true DK1071806T3 (da) 2004-07-19

Family

ID=22175690

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99918810T DK1071806T3 (da) 1998-04-24 1999-04-23 Rekombinant adeno-associeret virus-vektor, der koder for alpha-1-antitrypsin i genterapi

Country Status (11)

Country Link
US (4) US6461606B1 (da)
EP (1) EP1071806B1 (da)
AT (1) ATE269412T1 (da)
AU (1) AU3663699A (da)
CA (1) CA2326327C (da)
DE (1) DE69918090T2 (da)
DK (1) DK1071806T3 (da)
ES (1) ES2219011T3 (da)
NZ (1) NZ507308A (da)
PT (1) PT1071806E (da)
WO (1) WO1999055564A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6759237B1 (en) * 1998-11-05 2004-07-06 The Trustees Of The University Of Pennsylvania Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
WO2001033957A1 (en) * 1999-11-05 2001-05-17 Kyowa Hakko Kogyo Co., Ltd. Transgenic non-human mammals for monitoring change in calcium ion concentration in cells
US6821775B1 (en) * 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
US7445929B2 (en) * 2000-05-26 2008-11-04 Dainippon Sumitomo Pharma Co., Ltd. Recombinant adenovirus vector having a reduced side effect
EP1390490B1 (en) * 2001-05-24 2009-04-15 Genzyme Corporation Muscle-specific expression vectors
US20070003518A1 (en) * 2002-04-19 2007-01-04 Atkinson Mark A Raav vector-based compositions and methods for the prevention and treatment of mammalian diseases
US7312202B2 (en) * 2003-02-18 2007-12-25 Board Of Regents, The University Of Texas System Rationally designed and chemically synthesized promoter for genetic vaccine and gene therapy
ES2247942B1 (es) * 2004-08-27 2006-10-01 Instituto Nacional De Investigacion Y Tecnologia Agraria Y Alimentaria (Inia) Construccion genica, vector y vacuna adn para la vacunacion de animales acuaticos.
US7479550B2 (en) * 2006-06-02 2009-01-20 The Board Of Regents Of The University Of Texas System Amyloid β gene vaccines
TWI478937B (zh) * 2008-01-15 2015-04-01 Abbvie Inc 改良之哺乳動物表現載體及其用途
AU2012327236B2 (en) 2011-10-28 2016-11-10 University Of Florida Research Foundation, Inc. Chimeric promoter for cone photoreceptor targeted gene therapy
CA3077804C (en) 2012-01-09 2023-07-25 Serpin Pharma, Llc Peptides and methods of using same
RS65152B1 (sr) 2015-02-05 2024-02-29 Canem Holdings Llc Preparati za lečenje granulomatoze sa poliangiitisom
SI3265571T1 (sl) 2015-03-03 2022-10-28 Fondazione Telethon Več vektorski sistem in njegove uporabe
WO2017040287A1 (en) 2015-08-28 2017-03-09 Serpin Pharma, Llc Methods for treatment of diseases
CN108431033A (zh) 2015-09-28 2018-08-21 泰莱托恩基金会 骨生长病症的治疗
ES2984415T3 (es) * 2017-12-12 2024-10-29 Kamada Ltd Métodos para inducir tolerancia inmunitaria y reducir la respuesta de anticuerpos anti-fármaco
US20190256867A1 (en) 2018-02-01 2019-08-22 Homology Medicines, Inc. Adeno-associated virus compositions for restoring pah gene function and methods of use thereof
US10610606B2 (en) 2018-02-01 2020-04-07 Homology Medicines, Inc. Adeno-associated virus compositions for PAH gene transfer and methods of use thereof
KR20230065367A (ko) * 2018-02-01 2023-05-11 호몰로지 메디슨, 인크. Pah 유전자 전달을 위한 아데노-연관 바이러스 조성물 및 이의 사용 방법
JP7244547B2 (ja) 2018-02-19 2023-03-22 ホモロジー・メディシンズ・インコーポレイテッド Ｆ８遺伝子機能を回復させるためのアデノ随伴ウイルス組成物及びその使用の方法
AU2019357039B2 (en) * 2018-10-12 2025-10-09 Genzyme Corporation Generation of improved human pah for treatment of severe PKU by liver-directed gene replacement therapy
US20220249703A1 (en) * 2019-02-15 2022-08-11 Allen Institute Artificial expression constructs for selectively modulating gene expression in selected neuronal cell populations
TW202140791A (zh) 2020-01-13 2021-11-01 美商霍蒙拉奇醫藥公司 治療苯酮尿症之方法
IL296986A (en) * 2020-04-06 2022-12-01 Homology Medicines Inc Adeno-associated virus preparations for ids gene transfer and methods of use thereof
TW202208632A (zh) 2020-05-27 2022-03-01 美商同源醫藥公司 用於恢復ｐａｈ基因功能的腺相關病毒組成物及其使用方法
WO2023213817A1 (en) 2022-05-02 2023-11-09 Fondazione Telethon Ets Gene therapy for gyrate atrophy of the choroid and retina
WO2024036250A2 (en) * 2022-08-10 2024-02-15 Homology Medicines, Inc. Adeno-associated virus compositions for arsa gene transfer and methods of use thereof
IT202300004443A1 (it) 2023-03-09 2024-09-09 Int Centre For Genetic Engineering And Biotechnology Icgeb Sequenza codificante per alfa galattosidasi a umana per il trattamento della malattia di fabry
WO2024258925A1 (en) 2023-06-12 2024-12-19 Children's Hospital Medical Center Aav-cftr vectors and methods of using same
CN117223676B (zh) * 2023-09-25 2024-08-20 武汉大学 面中部发育畸形动物选育方法、辅助选育试剂和预防药物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
US6261834B1 (en) * 1991-11-08 2001-07-17 Research Corporation Technologies, Inc. Vector for gene therapy
US5587308A (en) 1992-06-02 1996-12-24 The United States Of America As Represented By The Department Of Health & Human Services Modified adeno-associated virus vector capable of expression from a novel promoter
US5439824A (en) * 1993-05-06 1995-08-08 The United States Of America Increased expression of α-1-antitrypsin in expression vectors through the inclusion of intron II
WO1995013365A1 (en) 1993-11-09 1995-05-18 Targeted Genetics Corporation Generation of high titers of recombinant aav vectors
US5693531A (en) * 1993-11-24 1997-12-02 The United States Of America As Represented By The Department Of Health And Human Services Vector systems for the generation of adeno-associated virus particles
US5658785A (en) 1994-06-06 1997-08-19 Children's Hospital, Inc. Adeno-associated virus materials and methods
US6204059B1 (en) * 1994-06-30 2001-03-20 University Of Pittsburgh AAV capsid vehicles for molecular transfer
US5652224A (en) * 1995-02-24 1997-07-29 The Trustees Of The University Of Pennsylvania Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
US5858351A (en) 1996-01-18 1999-01-12 Avigen, Inc. Methods for delivering DNA to muscle cells using recombinant adeno-associated virus vectors
US5846528A (en) 1996-01-18 1998-12-08 Avigen, Inc. Treating anemia using recombinant adeno-associated virus virions comprising an EPO DNA sequence
US5780447A (en) * 1996-06-14 1998-07-14 St. Jude Children's Research Hospital Recombinant adeno-associated viral vectors
ES2215222T3 (es) * 1996-12-05 2004-10-01 Crucell Holland B.V. Modificacion genetica de celulas cepa de repoblacion hematopoyeticas de primates.
US6723707B1 (en) * 1997-08-25 2004-04-20 The Trustees Of The University Of Pennsylvania Use of insulin-like growth factor-I in muscle

Also Published As

Publication number Publication date
CA2326327C (en) 2009-06-16
WO1999055564A9 (en) 2000-04-06
US20030082162A1 (en) 2003-05-01
CA2326327A1 (en) 1999-11-04
US20090186002A1 (en) 2009-07-23
PT1071806E (pt) 2004-09-30
EP1071806A2 (en) 2001-01-31
AU3663699A (en) 1999-11-16
US20030095949A1 (en) 2003-05-22
NZ507308A (en) 2003-01-31
EP1071806B1 (en) 2004-06-16
ATE269412T1 (de) 2004-07-15
DE69918090T2 (de) 2005-06-16
ES2219011T3 (es) 2004-11-16
DE69918090D1 (de) 2004-07-22
HK1035205A1 (en) 2001-11-16
WO1999055564A1 (en) 1999-11-04
US6461606B1 (en) 2002-10-08
WO1999055564A8 (en) 1999-12-02

Similar Documents

Publication Publication Date Title
DK1071806T3 (da) Rekombinant adeno-associeret virus-vektor, der koder for alpha-1-antitrypsin i genterapi
DK1019073T3 (da) Apoliprotein A-I agonister og deres anvendelse til at behandle dyslipidæmiske lidelser
ATE304058T1 (de) Rekombinante mva viren und deren verwendung
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
ATE223484T1 (de) In prostata aktiver gewebespezifischer enhancer
ATE501722T1 (de) Therapeutische behandlung androgenrezeptorbedingter leiden
HUP0003924A2 (hu) Génterápiás megközelítések ApoA-I agonisták biztosítására, valamint ezek alkalmazása diszlipidémiás rendellenességek kezelésében
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
TR200100348T2 (tr) Gen tedavisi teknikleri
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
EP1351968A4 (en) MUTATIONS IN THE ALPHA1 SUBUNIT OF THE NEURONAL GENE SODIUM CHANNEL, ASSOCIATED POLYPEPTIDES, AND TREATMENT OF GEFS + SYNDROME (GENERALIZED EPILEPSY WITH FEBRILIS + CRISIS)
DE60315628D1 (de) Modifizierte cea nucleinsäure und expressionsvektoren
EP1371377A4 (en) GENDER THERAPY RHEUMATOID ARTHRITIS COMPOSITIONS CONTAINING A GENE ENCODING AN ANTI-ANGIOGENIC PROTEIN OR PARTS THEREOF (16.07.02)
ATE246924T1 (de) Neue therapeutische verwendung von nicergoline
DE69534753D1 (de) Nierenpolycystose-gen
DE60123833D1 (de) Entwurf und verwendung von verbesserten zink-chelatbildenden peptiden zur regulation von matrix-metalloproteinasen
DK0684842T3 (da) Præparat til behandling af tumorer og immunisering af organismer over for tumorer
BR112023024627A2 (pt) Proteínas renais de fusão ativas e métodos de tratamento usando as mesmas
DE69919578D1 (de) VERWENDUNG von NIEDERMOLEKULAREM HEPARIN zur Behandlung und/oder Prophylaxe motoneuronaler Krankheiten
DK0722496T3 (da) Farmaceutiske præparater og anvendelse af disse, især til behandling af neurodegenerative sygdomme
ATE364625T1 (de) Proteine aus yaba monkey tumor virus mit modulatorischer aktivität
DE602005021159D1 (de) Bakteriophagen- und prophagen-proteine in der krebsgentherapie
FR2813606B1 (fr) Proteine bard1 tronquee, et ses applications diagnostiques et therapeutiques
ATE247467T1 (de) Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin
DK1033993T3 (da) Anvendelse af Escherichia coli stamme DSM 6601 i veterinærsektoren til behandling af diarré